Your browser doesn't support javascript.
loading
Virus kinetics and biochemical derangements among children with Ebolavirus disease.
Kjaldgaard, Lindsey; Claude, Kasereka Masumbuko; Mukadi-Bamuleka, Daniel; Kitenge-Omasumbu, Richard; Dixit, Devika; Edidi-Atani, François; Kuamfumu, Meris Matondo; Bulabula-Penge, Junior; Mambu-Mbika, Fabrice; Tshiani-Mbaya, Olivier; Diaz, Janet; Mulangu, Sabue; Legand, Anais; Mbala-Kingebeni, Placide; Formenty, Pierre; Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques; Hawkes, Michael T.
Afiliação
  • Kjaldgaard L; Department of Paediatrics, University of Alberta, Edmonton, AB, Canada.
  • Claude KM; Member, Women and Children's Research Institute, University of Alberta, Edmonton, AB, Canada.
  • Mukadi-Bamuleka D; Department of Medicine, Université Catholique du Graben, Butembo, Democratic Republic of the Congo.
  • Kitenge-Omasumbu R; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Dixit D; Programme National d'Urgences et Actions Humanitaires (PNUAH), Ministry of Health of the Democratic Republic of the Congo (DRC), Democratic Republic of the Congo.
  • Edidi-Atani F; Department of Medicine, Division of Infectious Diseases, University of Saskatchewan, Saskatoon, SK, Canada.
  • Kuamfumu MM; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Bulabula-Penge J; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Mambu-Mbika F; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Tshiani-Mbaya O; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Diaz J; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Mulangu S; World Health Organization (WHO), Geneva, Switzerland.
  • Legand A; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Mbala-Kingebeni P; World Health Organization (WHO), Geneva, Switzerland.
  • Formenty P; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Ahuka-Mundeke S; World Health Organization (WHO), Geneva, Switzerland.
  • Muyembe-Tamfum JJ; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
  • Hawkes MT; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
EClinicalMedicine ; 53: 101638, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36105872
ABSTRACT

Background:

A paucity of data is available on virologic and biochemical characteristics of paediatric Ebolavirus disease (EVD), compared to adults.

Methods:

We conducted a retrospective chart review of children (<16 years old) and a comparator group of young adults (16-44 years) from two treatment centres during the 2018-2020 EVD epidemic in Eastern Democratic Republic of the Congo. Statistical methods included chi-squared and Fisher's exact tests (dichotomous and categorical variables), Mann-Whitney U-test (continuous variables), multivariable linear regression (for determinants of admission viral load), linear mixed-effects models (for analysis of longitudinal viral load), and Cox proportional hazard models (to examine risk factors for mortality).

Findings:

We included 73 children and 234 adults admitted from April to October 2019. Paediatric patients commonly had electrolytes imbalances hypokalaemia in 26/73 (36%), hyperkalaemia in 38/73 (52%), and hyponatraemia in 54/73 (74%). Hypoglycaemia occurred in 20/73 (27%), acute kidney injury in 43/73 (59%), and rhabdomyolysis in 35/73 (48%). Biochemical abnormalities were detected in a similar proportion of children and adults. The viral load (VL, log10 copies/mL) at admission (7.2 versus 6.5, p=0.0001), the peak viral load (7.5 versus 6.7, p=<0.0001), and the time for viraemia clearance (16 days versus 12 days, p=<0.0001) were significantly different in children. The duration of hospital stay was prolonged in children (20 versus 16 days, p=<0.0001). Risk factors for mortality in children were VL >7.6 log10copies/mL, alanine transaminase >525 U/L, C-reactive protein >100 mg/L, blood urea nitrogen >7.5 mmol/L, rhabdomyolysis, and.acute kidney injury.

Interpretation:

Paediatric EVD patients, like adults, experience multiorgan dysfunction with life-threatening electrolyte imbalances, hypoglycaemia, kidney injury, liver injury, and rhabdomyolysis. Paediatric patients have significantly higher VLs throughout the course of EVD than adults.

Funding:

This study was not funded.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article